INDGN Indegene Q4 FY26 results (Jan–Mar 2026) and concall
Indegene reported a milestone Q4 and full year FY26, with revenues exceeding ₹1,000 crores and ₹3,500 crores respectively for the first time, driven by strong customer growth and strategic GenAI-led innovation. Adjusted EBITDA showed robust growth, and cash generation was strong. However, reported PAT was impacted by one-time charges related to currency volatility and a legal settlement, though adjusted PAT showed positive growth. The company expressed confidence in FY27 growth, driven by scaling current initiatives and strategic acquisitions.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 37.8%, net profit up 33.3% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 282 | 287 | 267 | 256 | 307 +9% | 290 +1% | 368 +38% |
| EBITDA | 46 | 52 | 40 | 37 | 71 +54% | 38 −27% | 103 +158% |
| Net profit | 45 | 50 | 54 | 45 | 60 +33% | 35 −30% | 72 +33% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
